Health Technology Assessment for Decision Making 2021
THETA Collaborative has been offering the Health Technology Assessment for Decision Making (HTA4DM) workshop since 2011. The course is a product of collaboration between THETA, the Institute of Health, Policy, Management and Evaluation (IHPME), and the Department of Medicine, University of Toronto. In the past the course has been offered at the China National Health Development Research Center (CNHDRC), Peking University, China, and at the Department of Community Health and Epidemiology, Dalhousie University, Nova Scotia. See below for course details:
Dates:
Week 1: Sep 16 & 17
Week 2: Sep 23 & 24
Week 3: Sep 30 & Oct 1
Time: 1-5pm EST
These workshops will bring together experts from a range of disciplines to provide attendees with pragmatic tools for HTA. This three-week intensive workshop will be useful to individuals who use HTA to make real-world decisions relating to drugs, devices, and programs.
Virtual workshops via Zoom: link to be sent out to registered participants.
Contact Information
Karen Liu or Ayda Zokai
email: info@theta.utoronto.ca
Register Here:
https://ihpme.utoronto.ca/hta4dm-students-payment-page/
Course Fee: $950.00 including taxes
Key Features
- Intensive program over 6 half-days throughout a 3 week period
- Theory bursts in lecture format to introduce and explain key concepts
- Interactive sessions (small group learning and computer labs) to explore illustrative cases
Objectives
By the end of the course, participants will be able to review and assess:
- Measures of evidence
- Cost-effectiveness analyses
- Approaches to integrating social and ethical issues
Curriculum Details
Week 1: Clinical Evidence
Day 1 will discuss HTA processes, the how and why of HTA, how HTA organizations function, as well as examine the nature of clinical evidence. Participants will learn the strengths and weaknesses of alternative study designs such as randomized controlled trials and observational research and understand how evidence strength is graded. We will also review common measures of effectiveness used in the medical literature so participants can understand the outcomes that are commonly reported in health technology assessments.
Week 2: Economic Evidence
Day 2 will explore the idea of value - the relationship between cost and health benefit. Participants will learn the key concepts and designs in cost effectiveness analysis, how to perform a simple analysis, and how to appraise and interpret cost effectiveness analyses that are part of health technology assessments.
Week 3: Social and Ethical Issues
Day 3 will explore the social and ethical issues arising in the assessment of health technologies - why these issues are important and how they can be addressed. Participants will be introduced to methods for assessing stakeholder values and preferences through research evidence or stakeholder engagement, approaches to integrating ethics and social values considerations into HTA assessments, and the decision- making and appeal processes that can improve the fairness and legitimacy of HTA decisions.
Faculty Members 2021
The Faculty Members for this year’s HTA for Decision Makers include:
Lusine Abrahamyan, PhD
Clinical Epidemiologist, THETA; Assistant Professor, Institute of Health Policy, Management & Evaluation, University of Toronto
Murray Krahn, MD FRCPC
Director, THETA; Senior Scientist, Toronto General Research Institute; Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
Fiona Miller, PhD
Professor, Chair in Health Management Strategies, Institute of Health Policy, Management and Evaluation, University of Toronto;
Director, Health Policy and Ethics Division, THETA
Petros Pechlivanoglou, PhD
Scientist, Child Health Evaluative Sciences (CHES), The Hospital for Sick Children, Toronto
Valeria Rac, PhD
Scientist, Toronto General Hospital Research Institute; Associate Program Director, Director Clinical Research Division, THETA;
Assistant Professor, Institute of Health Policy, Management & Evaluation, University of Toronto
Beate Sander, PhD
Scientist, Toronto General Hospital Research Institute;
Associate Professor, Institute of Health Policy, Management and Evaluation, University of Toronto;
Adjunct Scientist, Institute for Clinical Evaluative Sciences (ICES)
Prakeshkumar Shah, MD FRCPC
Department of Paediatrics, Mount Sinai Hospital; Associate Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
HTA for Decision Making 2018: Toronto General Hospital, Toronto, Ontario
The 2018 Health Technology Assessment for Decision Making course was held on June 25-27, 2018, at the THETA Collaborative offices, Eaton Building, Toronto General Hospital 200 Elizabeth Street, Toronto. This course was again a product of collaboration between the Toronto Health Economics and Technology Assessment Collaborative (THETA), Institute of Health, Policy, Management and Evaluation, University of Toronto and Leslie Dan Faculty of Pharmacy, University of Toronto.
Download: 2018 HTA Institute Brochure
HTA Institute 2015: University of Toronto, Toronto, Ontario
The 2015 Health Technology Assessment Institute for Decision Makers course was held on September 28-30, 2015, at the Leslie Dan Faculty of Pharmacy, University of Toronto. That year the course was a product of collaboration between the Toronto Health Economics and Technology Assessment Collaborative (THETA), Institute of Health, Policy, Management and Evaluation, University of Toronto and Leslie Dan Faculty of Pharmacy, University of Toronto.
Download: 2015 HTA Institute Flyer
HTA Institute 2014: Halifax
The Canadian Agency for Drugs and Technologies in Health (CADTH), in association with the Toronto Health Economics and Technology Assessment Collaborative (THETA) and Maritime Strategy for Patient-Oriented Research Support Unit (MSSU), has offered the 2014 Health Technology Assessment for Decision Makers course. The HTA Institute brought together experts from a range of disciplines to provide attendees with pragmatic tools for HTA. This three-day intensive course was useful to individuals who use HTA to make decisions relating to drugs, devices, and programs. The session was hosted in collaboration with:
| Toronto Institute of Health, Policy, Management and Evaluation, University of Toronto Leslie Dan Faculty of Pharmacy, University of Toronto Health Quality Ontario CIHR-STIHR Health Care, Technology and Place Program | Halifax Department of Community Health and Epidemiology, Dalhousie University Capital District Health Authority IWK Health Centre Nova Scotia Health Research Foundation |
HTA Institute 2013: Toronto
HTA Institute 2012: China
HTA Institute 2012: Toronto
Download: Brochure